APO RESEARCH · REPORT
Vaccines
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Product & engineering
Understand the product.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Selected research
Industry Research
Vaccines Industry Research Report 2026
Market perspective
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
Report Scope
Read the full market overview
This report quantifies the global Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (K Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Vaccines Market by Company
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
Vaccines Segment by Type
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Vaccines Segment by Application
Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others
Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Recombinant Vaccines
- Viral Vaccines
- Polysaccharide Vaccines
- Others
Applications
- Rabies vaccine
- Influenza vaccine
- HPV vaccine
- Hepatitis B
- Hepatitis A
- Leprosy vaccine
- Polio vaccine
- JE vaccine
- Others
Companies covered
- GSK
- Sanofi
- Merck
- Pfizer
- Novartis(GSK)
- CSL
- MedImmune LLC
- J&J(Crucell)
- China National Biotec
- Tiantan
- Hualan
- Kangtai
- Hissen
- Jintan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Vaccines Market Size (2021-2032)
- 2.2.2 Global Vaccines Sales (2021-2032)
- 2.2.3 Global Vaccines Market Average Price (2021-2032)
- 2.3 Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Recombinant Vaccines
- 2.3.3 Viral Vaccines
- 2.3.4 Polysaccharide Vaccines
- 2.3.5 Others
- 2.4 Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Rabies vaccine
- 2.4.3 Influenza vaccine
- 2.4.4 HPV vaccine
- 2.4.5 Hepatitis B
- 2.4.6 Hepatitis A
- 2.4.7 Leprosy vaccine
- 2.4.8 Polio vaccine
- 2.4.9 JE vaccine
- 2.4.10 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Vaccines Sales (K Pcs) of Manufacturers (2021-2026)
- 3.3 Global Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Vaccines, Established Date
- 3.9 Global Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GSK
- 4.1.1 GSK Company Information
- 4.1.2 GSK Business Overview
- 4.1.3 GSK Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GSK Vaccines Product Portfolio
- 4.1.5 GSK Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Vaccines Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Vaccines Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Vaccines Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Novartis(GSK)
- 4.5.1 Novartis(GSK) Company Information
- 4.5.2 Novartis(GSK) Business Overview
- 4.5.3 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Novartis(GSK) Vaccines Product Portfolio
- 4.5.5 Novartis(GSK) Recent Developments
- 4.6 CSL
- 4.6.1 CSL Company Information
- 4.6.2 CSL Business Overview
- 4.6.3 CSL Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 CSL Vaccines Product Portfolio
- 4.6.5 CSL Recent Developments
- 4.7 MedImmune LLC
- 4.7.1 MedImmune LLC Company Information
- 4.7.2 MedImmune LLC Business Overview
- 4.7.3 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 MedImmune LLC Vaccines Product Portfolio
- 4.7.5 MedImmune LLC Recent Developments
- 4.8 J&J(Crucell)
- 4.8.1 J&J(Crucell) Company Information
- 4.8.2 J&J(Crucell) Business Overview
- 4.8.3 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 J&J(Crucell) Vaccines Product Portfolio
- 4.8.5 J&J(Crucell) Recent Developments
- 4.9 China National Biotec
- 4.9.1 China National Biotec Company Information
- 4.9.2 China National Biotec Business Overview
- 4.9.3 China National Biotec Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 China National Biotec Vaccines Product Portfolio
- 4.9.5 China National Biotec Recent Developments
- 4.10 Tiantan
- 4.10.1 Tiantan Company Information
- 4.10.2 Tiantan Business Overview
- 4.10.3 Tiantan Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Tiantan Vaccines Product Portfolio
- 4.10.5 Tiantan Recent Developments
- 4.11 Hualan
- 4.11.1 Hualan Company Information
- 4.11.2 Hualan Business Overview
- 4.11.3 Hualan Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hualan Vaccines Product Portfolio
- 4.11.5 Hualan Recent Developments
- 4.12 Kangtai
- 4.12.1 Kangtai Company Information
- 4.12.2 Kangtai Business Overview
- 4.12.3 Kangtai Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Kangtai Vaccines Product Portfolio
- 4.12.5 Kangtai Recent Developments
- 4.13 Hissen
- 4.13.1 Hissen Company Information
- 4.13.2 Hissen Business Overview
- 4.13.3 Hissen Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Hissen Vaccines Product Portfolio
- 4.13.5 Hissen Recent Developments
- 4.14 Jintan
- 4.14.1 Jintan Company Information
- 4.14.2 Jintan Business Overview
- 4.14.3 Jintan Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Jintan Vaccines Product Portfolio
- 4.14.5 Jintan Recent Developments
5 Global Vaccines Market Scenario by Region
- 5.1 Global Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Vaccines Sales by Region: 2021-2032
- 5.2.1 Global Vaccines Sales by Region: 2021-2026
- 5.2.2 Global Vaccines Sales by Region: 2027-2032
- 5.3 Global Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global Vaccines Revenue by Region: 2027-2032
- 5.4 North America Vaccines Market Facts & Figures by Country
- 5.4.1 North America Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Vaccines Sales by Country (2021-2032)
- 5.4.3 North America Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Vaccines Market Facts & Figures by Country
- 5.7.1 South America Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Vaccines Sales by Country (2021-2032)
- 5.7.3 South America Vaccines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Vaccines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Vaccines Sales by Type (2021-2032)
- 6.1.1 Global Vaccines Sales by Type (2021-2032) & (K Pcs)
- 6.1.2 Global Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Vaccines Sales by Application (2021-2032)
- 7.1.1 Global Vaccines Sales by Application (2021-2032) & (K Pcs)
- 7.1.2 Global Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Vaccines Value Chain Analysis
- 8.1.1 Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Vaccines Production Mode & Process
- 8.2 Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Vaccines Distributors
- 8.2.3 Vaccines Customers
9 Global Vaccines Analyzing Market Dynamics
- 9.1 Vaccines Industry Trends
- 9.2 Vaccines Industry Drivers
- 9.3 Vaccines Industry Opportunities and Challenges
- 9.4 Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst